Efficacy and Safety of Mycophenolate Mofetil Versus Intravenous Pulse Cyclophosphamide as Induction Therapy in Proliferative Lupus Nephritis

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

GADAKCHI LEYLA; HAJIALILO MEHRZAD; NAKHJAVANI MOHAMMAD REZA; ABEDI AZAR SIMA; KOLAHI SOUSAN; GOJAZADEH MORTEZA; EBRAHIMI ALI ASGHAR; MALEK MAHDAVI AIDA; NOSHAD HAMID; KHABBAZI ALIREZA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Kidney Diseases Year:2018 | Volume:12 | Issue:5 Page(s): 288-292

Download Full-Text

View:

267

Download:

268

Cites:

Information Journal Paper

Title

Efficacy and Safety of Mycophenolate Mofetil Versus Intravenous Pulse Cyclophosphamide as Induction Therapy in Proliferative Lupus Nephritis

Author(s)

Keywords

lupus nephritis

mycophenolate mofetil

cyclophosphamide

Abstract

Introduction. lupus nephritis is a common and severe manifestation of systemic lupus erythematosus that can lead to end-stage renal disease and death. The aim of this study was to compare the efficacy and safety of mycophenolate mofetil (MMF) and cyclophosphamide as induction therapy and subsequently as maintenance therapy for lupus nephritis. Materials and Methods. In this retrospective case-control study, 67 patients with proliferative lupus nephritis who were treated with MMF (n = 45) and pulse of intravenous cyclophosphamide (n = 22) were included. Remission of the kidney disease, mortality, and adverse events were evaluated and compared between the two groups. Results. The 45 patients treated with MMF had a mean age of 33. 8 ± 10. 6 years and 17. 1% of them were males. The 22 patients treated with pulse of intravenous cyclophosphamide had a mean age of 38. 1 ± 11. 1 years and 18. 2% of them were males. Complete and partial kidney remission occurred in 40% and 42. 2% of the patients treated with MMF and in 31. 8% and 59. 1% of the patients treated with cyclophosphamide, respectively. No significant differences were observed in complete and partial remission between the two groups. No mortality was reported in the studied patients. There were no significant differences in the frequency of adverse events between the two groups. Conclusions. The efficacy of MMF in long-term treatment of lupus nephritis was comparable to that of cyclophosphamide, and there is no significant differences in the rate of side effects between the two regimens.

Multimedia

No record.

Cites

No record.

References

No record.

Cite

APA: Copy

GADAKCHI, LEYLA, HAJIALILO, MEHRZAD, NAKHJAVANI, MOHAMMAD REZA, ABEDI AZAR, SIMA, KOLAHI, SOUSAN, GOJAZADEH, MORTEZA, EBRAHIMI, ALI ASGHAR, MALEK MAHDAVI, AIDA, NOSHAD, HAMID, & KHABBAZI, ALIREZA. (2018). Efficacy and Safety of Mycophenolate Mofetil Versus Intravenous Pulse Cyclophosphamide as Induction Therapy in Proliferative Lupus Nephritis. IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), 12(5), 288-292. SID. https://sid.ir/paper/309727/en

Vancouver: Copy

GADAKCHI LEYLA, HAJIALILO MEHRZAD, NAKHJAVANI MOHAMMAD REZA, ABEDI AZAR SIMA, KOLAHI SOUSAN, GOJAZADEH MORTEZA, EBRAHIMI ALI ASGHAR, MALEK MAHDAVI AIDA, NOSHAD HAMID, KHABBAZI ALIREZA. Efficacy and Safety of Mycophenolate Mofetil Versus Intravenous Pulse Cyclophosphamide as Induction Therapy in Proliferative Lupus Nephritis. IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD)[Internet]. 2018;12(5):288-292. Available from: https://sid.ir/paper/309727/en

IEEE: Copy

LEYLA GADAKCHI, MEHRZAD HAJIALILO, MOHAMMAD REZA NAKHJAVANI, SIMA ABEDI AZAR, SOUSAN KOLAHI, MORTEZA GOJAZADEH, ALI ASGHAR EBRAHIMI, AIDA MALEK MAHDAVI, HAMID NOSHAD, and ALIREZA KHABBAZI, “Efficacy and Safety of Mycophenolate Mofetil Versus Intravenous Pulse Cyclophosphamide as Induction Therapy in Proliferative Lupus Nephritis,” IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), vol. 12, no. 5, pp. 288–292, 2018, [Online]. Available: https://sid.ir/paper/309727/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops